docetaxel,sotorasib
amgen
['sclc', 'lung', 'nsclc', 'biomarker', 'codebreak 200']
in a session on #lungcancer at #asco23, shares biomarker analyses of codebreak 200, a phase 3 trial of investigating pretreated kras g12c-mutated advanced #nsclc: #crukfunded
We're here to support our broad cancer research community of 4,000 scientists and clinicians. For general Cancer Research UK news & fundraising follow @CR_UK